Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report

Ralph, 2010, The management of Peyronie's disease: evidence-based 2010 guidelines, J Sex Med, 7, 2359, 10.1111/j.1743-6109.2010.01850.x Dibenedetti, 2011, Population-based study of Peyronie's disease: prevalence and treatment patterns in the United States, Adv Urol, 2011, 282503, 10.1155/2011/282503 Pryor, 2002, Clinical presentations of Peyronie's disease, Int J Impot Res, 14, 414, 10.1038/sj.ijir.3900877 Mulhall, 2006, An analysis of the natural history of Peyronie's disease, J Urol, 175, 2115, 10.1016/S0022-5347(06)00270-9 Levine, 2013, Peyronie's disease: a contemporary review of non-surgical treatment, Arab J Urol, 11, 278, 10.1016/j.aju.2013.03.008 Sherer, 2016, Contemporary review of treatment options for Peyronie's disease, Urology, 95, 16, 10.1016/j.urology.2016.02.009 Abern, 2012, Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease, J Sex Med, 9, 288, 10.1111/j.1743-6109.2011.02519.x Paulis, 2013, Long-term multimodal therapy (verapamil associated with propolis, blueberry, vitamin E and local diclofenac) on patients with Peyronie's disease (chronic inflammation of the tunica albuginea). Results of a controlled study, Inflamm Allergy Drug Targets, 12, 403, 10.2174/1871528112666131205112432 Favilla, 2014, Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study, Andrologia, 46, 936, 10.1111/and.12178 Alizadeh, 2014, Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline, Glob J Health Sci, 6, 23, 10.5539/gjhs.v6n7p23 Dell’Atti, 2015, Tadalafil once daily and intralesional verapamil injection: a new therapeutic direction in Peyronie's disease, Urol Ann, 7, 345, 10.4103/0974-7796.152048 Yafi, 2015, The effect of duration of penile traction therapy in patients undergoing intralesional injection therapy for Peyronie's disease, J Urol, 194, 754, 10.1016/j.juro.2015.03.092 Taylor, 2008, Non-surgical therapy of Peyronie's disease, Asian J Androl, 10, 79, 10.1111/j.1745-7262.2008.00351.x Schandené, 1992, Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells, Immunology, 76, 30 Raetsch, 2002, Pentoxifylline downregulates profibrogenic cytokines and procollagen i expression in rat secondary biliary fibrosis, Gut, 50, 241, 10.1136/gut.50.2.241 Safarinejad, 2010, A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease, BJU Int, 106, 240, 10.1111/j.1464-410X.2009.09041.x Smith, 2011, Pentoxifylline treatment and penile calcifications in men with Peyronie's disease, Asian J Androl, 13, 322, 10.1038/aja.2010.117 Valente, 2003, l-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures, Nitric Oxide, 9, 229, 10.1016/j.niox.2003.12.002 Roth, 1996, Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix, Proc Natl Acad Sci U S A, 93, 5478, 10.1073/pnas.93.11.5478 Mulhall, 2002, Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses, Int J Impot Res, 14, 397, 10.1038/sj.ijir.3900874 Levine, 1994, Intralesional verapamil injection for the treatment of Peyronie's disease, J Urol, 151, 1522, 10.1016/S0022-5347(17)35291-6 Larsen, 2012, Review of non-surgical treatment options for Peyronie's disease, Int J Impot Res, 24, 1, 10.1038/ijir.2011.45 Levine, 2008, Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study, J Sex Med, 5, 1468, 10.1111/j.1743-6109.2008.00814.x Martínez-Salamanca, 2014, Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation, J Sex Med, 11, 506, 10.1111/jsm.12400 Wolff, 2015, Intralesional injections for early Peyronie disease: standardized assessment and analysis of predictive factors for treatment response, Urology, 86, 57, 10.1016/j.urology.2015.03.010 Levine, 2002, Experience with intraplaque injection of verapamil for Peyronie's disease, J Urol, 168, 621, 10.1016/S0022-5347(05)64691-5 Rehman, 1998, Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study, Urology, 51, 620, 10.1016/S0090-4295(97)00700-0 Shirazi, 2009, Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study, Int Urol Nephrol, 41, 467, 10.1007/s11255-009-9522-4 Nikoobakht, 2011, Effect of penile-extender device in increasing penile size in men with shortened penis: preliminary results, J Sex Med, 8, 3188, 10.1111/j.1743-6109.2009.01662.x